Aiba Takayuki, Akagi Tomonori, Shiroshita Hidefumi, Nakajima Kentaro, Ohyama Tetsuji, Kinjo Tatsuya, Kanazawa Akiyoshi, Suzuki Nobuaki, Tokunaga Takuya, Yamamoto Manabu, Ichikawa Nobuki, Endo Shungo, Kojima Yutaka, Nakamura Takatoshi, Saito Shuji, Kagawa Yoshinori, Ohnuma Shinobu, Yamamoto Seiichiro, Naitoh Takeshi, Inomata Masafumi
Department of Gastroenterological and Pediatric Surgery Oita University Faculty of Medicine Yufu Japan.
Department of Surgery NTT Medical Center Tokyo Shinagawa-ku Japan.
Ann Gastroenterol Surg. 2025 Jan 23;9(3):392-400. doi: 10.1002/ags3.12916. eCollection 2025 May.
The impact of obesity on colon cancer remains unclear. Very few studies of colon cancer surgery have analyzed body mass index (BMI) as a continuous variable, with no such reports from Japan. This study examined the association between BMI as a continuous variable and short- and long-term outcomes of laparoscopic surgery for obese colon cancer patients.
Obese (BMI ≥25 kg/m) patients who underwent laparoscopic radical surgery for Stage II/III colon cancer at 46 participating centers from 2009 to 2013 were included. Associations between short- and long-term outcomes and BMI as a continuous variable were analyzed by univariate and multivariate regression models.
Among patients meeting the study criteria, 1036 were examined. BMI as a continuous variable correlated with log-transformed operative time (regression coefficient: 0.02, 95% confidence interval [CI]: 0.012-0.028, < 0.05) and blood loss (odds ratio: 1.089, 95% CI: 1.032-1.149, < 0.05). There was no association between BMI continuous variables and 3-year relapse-free survival (RFS) and overall survival. However, 3-year RFS was possibly better in patients with BMI ≥28.5 kg/m versus those with BMI <28.5 kg/m (hazard ratio: 0.682, 95% CI: 0.462-1.008, = 0.055).
This study showed that BMI as a continuous variable correlated with operative time and blood loss. RFS was possibly better in the severely obese patients (BMI ≥28.5 kg/m), suggesting that the prognosis for highly obese colon cancer patients appears to follow the obesity paradox.
肥胖对结肠癌的影响尚不清楚。很少有结肠癌手术研究将体重指数(BMI)作为连续变量进行分析,日本尚无此类报告。本研究探讨了BMI作为连续变量与肥胖结肠癌患者腹腔镜手术短期和长期结局之间的关联。
纳入2009年至2013年在46个参与中心接受腹腔镜根治性手术治疗II/III期结肠癌的肥胖(BMI≥25kg/m)患者。通过单因素和多因素回归模型分析短期和长期结局与BMI作为连续变量之间的关联。
在符合研究标准的患者中,对1036例进行了检查。BMI作为连续变量与对数转换后的手术时间(回归系数:0.02,95%置信区间[CI]:0.012 - 0.028,P<0.05)和失血量(优势比:1.089,95%CI:1.032 - 1.149,P<0.05)相关。BMI连续变量与3年无复发生存期(RFS)和总生存期之间无关联。然而,BMI≥28.5kg/m的患者与BMI<28.5kg/m的患者相比,3年RFS可能更好(风险比:0.682,95%CI:0.462 - 1.008,P = 0.055)。
本研究表明,BMI作为连续变量与手术时间和失血量相关。重度肥胖患者(BMI≥28.5kg/m)的RFS可能更好,这表明高度肥胖结肠癌患者的预后似乎符合肥胖悖论。